300942 易瑞生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资63,991-18.50%78,520100,690145,179195,758
投资性房地产0--0000
固定资产565,418-1.84%576,013363,11157,10283,986
在建工程3,01733.38%2,262199,793356,626190,867
无形资产36,378-2.61%37,35139,24341,39342,400
商誉0--0000
其他非流动资产17,32437.62%12,5882,71318,37095,026
686,128-2.92%706,734705,550618,669608,036

流动资产
货币资金461,19117.40%392,838293,399481,749247,451
应收账款115,3584.67%110,21094,05976,14883,878
存货64,76018.23%54,77440,43031,461100,608
其他流动资产152,753-41.25%259,991323,728148,312242,482
794,063-2.90%817,814751,616737,670674,419

流动负债
短期借款11,000-47.62%21,000000
应付票据0--0000
应付帐款45,874-37.12%72,95558,76277,35265,107
其他流动负债63,237-5.26%66,74893,19559,575134,676
120,110-25.26%160,703151,958136,927199,784
流动资产净值673,9522.56%657,111599,658600,743474,636
资产总额减流动负债1,360,080-0.28%1,363,8451,305,2081,219,4121,082,672

非流动负债
长期借款171,2989.83%155,967163,218100,32956,320
应付债券266,9333.85%257,030263,169245,4520
其他非流动负债41,402-4.09%43,1688,57924,90361,651
479,6345.15%456,164434,966370,684117,971

总权益
    实收股本405,0780.00%405,069401,317400,860400,860
    储备项目468,922-6.03%499,011467,689448,134564,031
股东权益874,000-3.33%904,080869,005848,994964,891
非控股权益6,44779.08%3,6001,237(266)(190)